シロリムス溶出ステント
WordNet
- a slender tube inserted inside a tubular body part (as a blood vessel) to provide support during and after surgical anastomosis
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Comparison of Outcomes Using the Sirolimus-Eluting Stent in Calcified Versus Non-Calcified Native Coronary Lesions in Patients On- Versus Not On-Chronic Hemodialysis (from the j-Cypher Registry).
- Nishida K, Kimura T, Kawai K, Miyano I, Nakaoka Y, Yamamoto S, Kaname N, Seki S, Kubokawa S, Fukatani M, Hamashige N, Morimoto T, Mitsudo K; j-Cypher Registry Investigators.SourceDivision of Cardiology, Chikamori Hospital, Kochi, Japan.
- The American journal of cardiology.Am J Cardiol.2013 Sep 1;112(5):647-55. doi: 10.1016/j.amjcard.2013.04.043. Epub 2013 May 21.
- The impact of lesion calcium on long-term outcomes after drug-eluting stent implantation has not been adequately addressed. In 10,595 patients (16,803 lesions) who were exclusively treated with sirolimus-eluting stents in the j-Cypher registry, 5-year outcomes were compared between patients with ≥
- PMID 23707041
- Accelerated endothelialization with a polymer-free sirolimus-eluting antibody-coated stent.
- Yu Z, Zhu H, Lü S, Yang X.SourceState Key Laboratory of Natural and Biomimetic Drugs and Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, People's Republic of China.
- Journal of materials science. Materials in medicine.J Mater Sci Mater Med.2013 Aug 23. [Epub ahead of print]
- Drug-eluting stents have shown an impressive reduction of in-stent restenosis for many years. However, stent thrombosis due to incomplete/late endothelialization has raised major safety concerns. To overcome these problems, we developed for the first time a polymer-free sirolimus-eluting antibody-co
- PMID 23975333
- First-in-human evaluation of the novel BioMime sirolimus-eluting coronary stent with bioabsorbable polymer for the treatment of single de novo lesions located in native coronary vessels - results from the meriT-1 trial.
- Dani S, Costa RA, Joshi H, Shah J, Pandya R, Virmani R, Sheiban I, Bhatt S, Abizaid A.SourceLifecare Institute of Medical Sciences and Research, Ahmedabad, Gujarat, India.
- EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.EuroIntervention.2013 Aug 22;9(4):493-500. doi: 10.4244/EIJV9I4A79.
- Aims: We report the initial human evaluation of the novel BioMimeTM sirolimus-eluting stent (SES) (Meril Life Sciences Pvt. Ltd., Gujarat, India) with an ultra-thin stent platform (65 μm) and a biodegradable polymer for the treatment of de novo coronary lesions. Methods and results: The meriT-1 tri
- PMID 23965355
Japanese Journal
- Pathological analyses of very long-term sirolimus-eluting stent implantation in human coronary artery
- Imai Masao,Kimura Takeshi,Tazaki Junichi,Yamamoto Erika,Inoue Katsumi
- Journal of Cardiology Cases 8(5), 145-147, 2013-11-00
- … A 73-year-old man underwent sirolimus-eluting stent (SES) implantation for chest pain on exertion with left anterior descending coronary artery (LAD) and left circumflex coronary artery (LCX). … In spite of these findings, observations of neointimal rupture and stent thrombosis were not found in this very late period autopsy study. …
- NAID 120005341899
- Evaluation of intravascular ultrasound findings in 5 cases of very late stent thrombosis after sirolimus-eluting stent implantation
- 加藤 真史,鈴木 啓之,水崎 繁,岩田 昭夫,西川 英郎
- Journal of the Japanese Coronary Association, 2013
- … Objective: We examined intravascular ultrasound (IVUS) findings in patients who had very late stent thrombosis (VLST) after sirolimus-eluting stent implantation. … Late incomplete stent apposition and vessel remodeling was found in all cases. …
- NAID 130003379678
- Consideration of Dual Anti-platelet Therapy Duration after Drug-eluting Stent Implantation in a Japanese Population: A Five-year Follow-up after Sirolimus-Eluting Stent Implantation
- Kotani Jun-ichi,Ikari Yuji,Kyo Eishou,Nakamura Masato,Yokoi Hiroyoshi
- Internal Medicine 52(7), 703-711, 2013
- … Objective To investigate the risks and benefits of prolonged dual antiplatelet therapy (DAPT: thienopyridine plus aspirin) following placement of drug-eluting stents (DES). … Methods We analyzed a prospective registry of 2,050 patients with sirolimus-eluting stents during a 5-year follow-up. …
- NAID 130003365956
Related Links
- Sirolimus Eluting Wrong Sirolimus Eluting? Try Again Others With a Similar Name Endeavor Zotarolimus-Eluting Stent Mobile Find Friends Badges People Pages Places Apps Games Music About Create Ad Create Page Careers ...
- 1. Am J Cardiovasc Drugs. 2003;3(3):211-30. The sirolimus-eluting stent: a review of its use in the treatment of coronary artery disease. McKeage K, Murdoch D, Goa KL. Adis International Inc, Yardley, PA 19067, USA. demail@adis ...
★リンクテーブル★
[★]
シロリムス溶出ステント sirolimus-eluting stent
[★]
- 英
- sirolimus-eluting stent, SES
[★]
シロリムス溶出ステント
[★]
- 関
- stent implantation、stent placement、stented
[★]
- 関
- stent implantation、stent placement、stenting